Trademark Attorney / Law Firm
Sean C. Myers-Payne – Trademark Portfolio
Sean C. Myers-Payne specializes in Class 5 (Pharmaceuticals) trademark filings before the United States Patent and Trademark Office (USPTO), with 3 of 4 total filings concentrated in this category. The practice also covers Class 35 (Advertising & Business) along with 3 other Nice Classification classes. Filing activity spans from 1986 to 2004. Currently, 1 trademark is registered.
Showing of trademarks Trademarks
Practice Areas by Trademark Class
Sean C. Myers-Payne's trademark practice covers 3 Nice Classification classes, representing the range of industries and goods/services handled in their USPTO filings.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Advertising; business management; business administration; office functions
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademark applications has Sean C. Myers-Payne filed?
Sean C. Myers-Payne has filed 4 trademark applications with the United States Patent and Trademark Office (USPTO). Of these, 1 registered, 3 cancelled.
What trademark classes does Sean C. Myers-Payne specialize in?
Sean C. Myers-Payne has filed trademarks across 3 Nice Classification classes. The most common practice areas include Class 5 (Pharmaceuticals), Class 35 (Advertising & Business), Class 44 (Medical Services). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
How long has Sean C. Myers-Payne been filing trademarks?
Sean C. Myers-Payne's trademark filing history with the USPTO spans from 1986 to 2004, covering 18 years of trademark practice. During this period, Sean C. Myers-Payne has handled 4 trademark applications.
What is Sean C. Myers-Payne's trademark registration success rate?
Sean C. Myers-Payne has a 25% trademark registration rate, with 1 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.